Prime Global announces acquisition of Cambridge Medical Communication

Prime Global, the international medical communications and market access group, today announced the acquisition of Cambridge Medical Communication, an independent medical communications agency based near Cambridge, UK. Cambridge Medical Communication will join Prime Global’s existing group of six agencies and two consultancies to deliver brilliant medical communications, focusing on scientific excellence coupled with innovative execution.  “We are very pleased to welcome Cambridge Medical Communication to Prime Global; I am excited to be working with Jenny and her team!” says Graeme Peterson PhD, Chairman and CEO of Prime Global. “Not only is this the next step of our ongoing and successful growth plan, acquiring Cambridge strengthens our scientific excellence, allowing us to establish a new office near the city of Cambridge, one of the largest centres for scientific research in Europe, and also to expand our European client base.” Founded in 1998 by their Managing Director, Jenny Muiry PhD, Cambridge Medical Communication has built up a formidable reputation for providing clear and imaginative medical communication materials. Jenny says, “Becoming part of Prime Global will provide our staff and our clients with additional resources, including access to specialised in-house teams, such as Creative, Digital, and Strategy. With our shared commitment to deliver excellence and maintain long-lasting relationships with our clients, I look forward to working alongside Graeme and the rest of the Prime Global team.” Prime Global has experienced exceptional organic growth in recent years, including the recent launch of Prime Access, a Market Access consultancy. The company is proud to rank on several business growth lists such as the Sunday Times Fast Track 100 in 2018 and 2019, and of being selected as consultancy growth winners of the Alantra Fast Pharma 50 in 2019 and 2020. The addition of Cambridge Medical Communication continues this expansion trend and is a strong cultural fit; both companies share the values of passion, excellence, and partnership. 

About Prime Global Prime Global is an international medical communications and market access group. Founded in 1997 by the CEO and Managing Director, Graeme Peterson PhD, it comprises seven agencies (Prime, Spark, Onyx, Paragon, Scion, Core, and now Cambridge), two consultancies (Prime Access and Only Oncology), as well as group-level teams for Creative, Strategy, Digital, and more. Prime Global is rapidly growing, successful, and wholly independently owned. It employs over 230 people, with offices in the UK (London, Knutsford, Macclesfield, Brighton, Oxford and now Cambridge), the US (New York and San Francisco), and satellite locations in San Diego, Germany, and New Zealand. Prime Global provides the world’s leading biotech, pharma and healthcare businesses with fullservice professional communications covering healthcare strategy and consultancy, scientific and medical communications, consumer health, patient integrated science, and market access. Our highly qualified scientific teams deliver expertise across a wide range of therapy areas such as oncology, cardiovascular, diabetes and metabolic disorders, central nervous system and neurosciences, respiratory, infectious diseases, vaccines, HIV and virology, devices and diagnostics, sexual health and urology, nephrology, haematology, dermatology, gastrointestinal, rare and genetic disorders, and immuno-inflammation and allergy. We believe passionately in the value of innovative and creative science communication to further our understanding of the world, and to benefit patients everywhere. Our philosophy is ‘people first’. People are at the heart of everything we do, from the colleagues we work with to the clients we support every day, and ultimately the patients helped by their products and services.  www.primeglobalpeople.com